Rankings
▼
Calendar
IVVD Q2 2023 Earnings — Invivyd, Inc. Revenue & Financial Results | Market Cap Arena
IVVD
Invivyd, Inc.
$257M
Q2 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$54M
Net Income
-$50M
EPS (Diluted)
$-0.46
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$37M
Free Cash Flow
-$37M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$315M
Total Liabilities
$34M
Stockholders' Equity
$282M
Cash & Equivalents
$122M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$54M
-$52M
-4.1%
Net Income
-$50M
-$51M
+1.5%
← FY 2023
All Quarters
Q3 2023 →